Skip to main content
. 2017 May 15;130(2):205–213. doi: 10.1182/blood-2017-02-767624

Table 1.

Baseline clinical and laboratory characteristics of study participants

Characteristic Value
Age, mean ± SD (range), y 23 ± 13 (6-61)
Female, n (%) 14 (56)
Receiving hydroxyurea, n (%) 19 (76)
Heart rate, bpm 78 ± 12
Systolic blood pressure, mmHg 125 ± 16
Diastolic blood pressure, mmHg 63 ± 9
White blood cell count, 103/mm3 9.5 ± 3.4
Hemoglobin, g/dL 9.7 ± 1.5
Hematocrit, % 27.7 ± 4.2
Reticulocyte count, % 8.3 ± 5.2
Platelet count, 103/mm3 341 ± 94
Bilirubin, mg/dL 2.4 ± 1.5
AST, U/L 48 ± 28
LDH, U/L 556 ± 267
Plasma free hemoglobin, mg/dL 75.3 ± 102
Nucleated RBC, cell/100 WBC 6.2 ± 17
Fetal hemoglobin, % 17.8 ± 12.5
Mean corpuscular volume, fL 94.3 ± 19
Absolute neutrophil count, K/μL 4.9 ± 2.5
Creatinine, mg/dL 0.58 ± 0.2
Cystatin C, mg/L 0.67 ± 0.18
GFR, mL/min per 1.73 m2 139.7 ± 38
Aldosterone, ng/dL 8.8 ± 6.1
Plasma renin activity, ng/mL per hour 1.86 ± 1.4
NT-proBNP, pg/mL 127.1 ± 182.8

Values are shown as mean ± standard deviation unless otherwise specified.

AST, aspartate aminotransferase; GFR, glomerular filtration rate; LDH, lactate dehydrogenase; RBC, red blood cell; SD, standard deviation; WBC, white blood cell.